ST2 Predicts Mortality In Patients With Acute Hypercapnic Respiratory Failure Treated With Noninvasive Positive Pressure Ventilation

References

• Stokes NR, Dietz BW, Liang JJ. Cardiopulmonary laboratory biomarkers in the evaluation of acute dyspnea. Open Access Emerg Med. 2016;8:35–45. doi:10.2147/OAEM.S7144627307771
   PubMedGoogle Scholar
• Dieplinger B, Gegenhuber A, Kaar G, Poelz W, Haltmayer M, Mueller T. Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department. Clin Biochem. 2010;43(9):714–719. doi:10.1016/j.clinbiochem.2010.02.00220153308
   PubMed Web of Science ®Google Scholar
• DeVos E, Jacobson L. Approach to adult patients with acute dyspnea. Emerg Med Clin North Am. 2016;34(1):129–149. doi:10.1016/j.emc.2015.08.00826614245
   PubMed Web of Science ®Google Scholar
• Parshall MB, Schwartzstein RM, Adams L, et al. An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea. Am J Respir Crit Care Med. 2012;185(4):435–452. doi:10.1164/rccm.201111-2042ST22336677
   PubMed Web of Science ®Google Scholar
• Roberts CM, Stone RA, Buckingham RJ, Pursey NA, Lowe D. Acidosis, non-invasive ventilation and mortality in hospitalised COPD exacerbations. Thorax. 2011;66(1):43–48. doi:10.1136/thx.2010.15311421075776
   PubMed Web of Science ®Google Scholar
• Schnell D, Timsit JF, Darmon M, et al. Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes. Intensive Care Med. 2014;40(4):582–591. doi:10.1007/s00134-014-3222-y24504643
   PubMed Web of Science ®Google Scholar
• Bello G, De Pascale G, Antonelli M. Noninvasive ventilation. Clin Chest Med. 2016;37(4):711–721. doi:10.1016/j.ccm.2016.07.01127842751
   PubMed Web of Science ®Google Scholar
• Cabrini L, Landoni G, Oriani A, et al. Noninvasive ventilation and survival in acute care settings: a comprehensive systematic review and metaanalysis of randomized controlled trials. Crit Care Med. 2015;43(4):880–888. doi:10.1097/CCM.000000000000081925565461
   PubMed Web of Science ®Google Scholar
• Roberts CM, Brown JL, Reinhardt AK, et al. Non-invasive ventilation in chronic obstructive pulmonary disease: management of acute type 2 respiratory failure. Clin Med. 2008;8(5):517–521. doi:10.7861/clinmedicine.8-5-517
   Web of Science ®Google Scholar
• Celikel T, Sungur M, Ceyhan B, Karakurt S. Comparison of noninvasive positive pressure ventilation with standard medical therapy in hypercapnic acute respiratory failure. Chest. 1998;114(6):1636–1642. doi:10.1378/chest.114.6.16369872200
   PubMed Web of Science ®Google Scholar
• Osadnik CR, Tee VS, Carson-Chahhoud KV, Picot J, Wedzicha JA, Smith BJ. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2017;7:Cd004104. doi:10.1002/14651858.CD003881.pub428702957
   PubMed Web of Science ®Google Scholar
• Lightowler JV, Wedzicha JA, Elliott MW, Ram FS. Non-invasive positive pressure ventilation to treat respiratory failure resulting from exacerbations of chronic obstructive pulmonary disease: cochrane systematic review and meta-analysis. BMJ (clinical Research Ed). 2003;326(7382):185. doi:10.1136/bmj.326.7402.1329-b
   PubMed Web of Science ®Google Scholar
• Plant PK, Owen JL, Elliott MW. Non-invasive ventilation in acute exacerbations of chronic obstructive pulmonary disease: long term survival and predictors of in-hospital outcome. Thorax. 2001;56(9):708–712. doi:10.1136/thorax.56.9.70811514692
   PubMed Web of Science ®Google Scholar
• Mas A, Masip J. Noninvasive ventilation in acute respiratory failure. Int J Chron Obstruct Pulmon Dis. 2014;9:837–852. doi:10.2147/COPD.S4266425143721
   PubMed Web of Science ®Google Scholar
• Davidson AC, Banham S, Elliott M, et al. BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults. Thorax. 2016;71(Suppl 2):ii1–i35. doi:10.1136/thoraxjnl-2015-20820926976648
   PubMed Web of Science ®Google Scholar
• Confalonieri M, Potena A, Carbone G, Porta RD, Tolley EA, Umberto Meduri G. Acute respiratory failure in patients with severe community-acquired pneumonia. A prospective randomized evaluation of noninvasive ventilation. Am J Respir Crit Care Med. 1999;160(5 Pt 1):1585–1591. doi:10.1164/ajrccm.160.5.990301510556125
   PubMed Web of Science ®Google Scholar
• Bello G, De Pascale G, Antonelli M. Noninvasive ventilation for the immunocompromised patient: always appropriate? Curr Opin Crit Care. 2012;18(1):54–60. doi:10.1097/MCC.0b013e32834e7c2122143051
   PubMed Web of Science ®Google Scholar
• Vital FM, Ladeira MT, Atallah AN. Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema. Cochrane Database Syst Rev. 2013;31(5):Cd005351.
   Google Scholar
• Adler D, Pepin JL, Dupuis-Lozeron E, et al. Comorbidities and subgroups of patients surviving severe acute hypercapnic respiratory failure in the intensive care unit. Am J Respir Crit Care Med. 2017;196(2):200–207. doi:10.1164/rccm.201608-1666OC27973930
   PubMed Web of Science ®Google Scholar
• Ciccone MM, Cortese F, Gesualdo M, et al. A novel cardiac bio-marker: ST2: a review. Molecules. 2013;18(12):15314–15328. doi:10.3390/molecules18121531424335613
   PubMed Web of Science ®Google Scholar
• Januzzi JL Jr. ST2 as a cardiovascular risk biomarker: from the bench to the bedside. J Cardiovasc Transl Res. 2013;6(4):493–500. doi:10.1007/s12265-013-9459-y23558647
   PubMed Web of Science ®Google Scholar
• Mueller T, Dieplinger B. Soluble ST2 and galectin-3: what we know and don’t know analytically. Ejifcc. 2016;27(3):224–237.27683536
   PubMedGoogle Scholar
• Januzzi JL Jr., Peacock WF, Maisel AS, et al. Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. J Am Coll Cardiol. 2007;50(7):607–613. doi:10.1016/j.jacc.2007.05.01417692745
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Manzano-Fernandez S, Boronat M, et al. Soluble ST2, high-sensitivity troponin T- and N-terminal pro-B-type natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure. Eur J Heart Fail. 2011;13(7):718–725. doi:10.1093/eurjhf/hfr04721551163
   PubMed Web of Science ®Google Scholar
• Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB. Novel biomarkers for cardiovascular risk prediction. J Geriatr Cardiol. 2017;14(2):135–150. doi:10.11909/j.issn.1671-5411.2017.02.00828491088
   PubMedGoogle Scholar
• Ghashghaei R, Arbit B, Maisel AS. Current and novel biomarkers in heart failure: bench to bedside. Curr Opin Cardiol. 2016;31(2):191–195. doi:10.1097/HCO.000000000000025426814650
   PubMed Web of Science ®Google Scholar
• Maisel AS, Richards AM, Pascual-Figal D, Mueller C. Serial ST2 testing in hospitalized patients with acute heart failure. Am J Cardiol. 2015;115(7 Suppl):32b–37b. doi:10.1016/j.amjcard.2015.01.038
   PubMed Web of Science ®Google Scholar
• Bajwa EK, Mebazaa A, Januzzi JL. ST2 in pulmonary disease. Am J Cardiol. 2015;115(7 Suppl):44b–47b. doi:10.1016/j.amjcard.2015.01.040
   Web of Science ®Google Scholar
• Tajima S, Oshikawa K, Tominaga S, Sugiyama Y. The increase in serum soluble ST2 protein upon acute exacerbation of idiopathic pulmonary fibrosis. Chest. 2003;124(4):1206–1214. doi:10.1378/chest.124.4.120614555548
   PubMed Web of Science ®Google Scholar
• Hoogerwerf JJ, Tanck MW, van Zoelen MA, Wittebole X, Laterre PF, van der Poll T. Soluble ST2 plasma concentrations predict mortality in severe sepsis. Intensive Care Med. 2010;36(4):630–637. doi:10.1007/s00134-010-1773-020151106
   PubMed Web of Science ®Google Scholar
• Xia J, Zhao J, Shang J, et al. Increased IL-33 expression in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol. 2015;308(7):L619–L627. doi:10.1152/ajplung.00305.201425595648
   PubMed Web of Science ®Google Scholar
• Mueller T, Leitner I, Egger M, Haltmayer M, Dieplinger B. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases. Clin Chim Acta. 2015;445:155–160. doi:10.1016/j.cca.2015.03.03325850080
   PubMed Web of Science ®Google Scholar
• Jonsdottir B, Jaworowski A, San Miguel C, Melander O. IL-8 predicts early mortality in patients with acute hypercapnic respiratory failure treated with noninvasive positive pressure ventilation. BMC Pulm Med. 2017;17(1):35. doi:10.1186/s12890-017-0500-928178959
   PubMed Web of Science ®Google Scholar
• Lundberg M, Eriksson A, Tran B, Assarsson E, Fredriksson S. Homogeneous antibody-based proximity extension assays provide sensitive and specific detection of low-abundant proteins in human blood. Nucleic Acids Res. 2011;39(15):e102. doi:10.1093/nar/gkr42421646338
   PubMed Web of Science ®Google Scholar
• Proseek Multiplex. A Precision proteomics solution for targeted protein biomarker discovery; 2016 Available from: http://www.olink.com/products/proseek-multiplex/ Accessed 816, 2016.
   Google Scholar
• Presage® ST2 Assay. [Webpage]; 2018 Available from: http://www.sopachem.com/diagnostics/portfolio/presage-st2-assay/ Accessed 418, 2018.
   Google Scholar
• Manzano-Fernandez S, Januzzi JL, Pastor-Perez FJ, et al. Serial monitoring of soluble interleukin family member ST2 in patients with acutely decompensated heart failure. Cardiology. 2012;122(3):158–166. doi:10.1159/00033880022832599
   PubMed Web of Science ®Google Scholar
• Breidthardt T, Balmelli C, Twerenbold R, et al. Heart failure therapy-induced early ST2 changes may offer long-term therapy guidance. J Card Fail. 2013;19(12):821–828. doi:10.1016/j.cardfail.2013.11.00324239955
   PubMed Web of Science ®Google Scholar